SynthesisFrontiers in immunology2024

Evaluation of the effectiveness and safety of combining PD-1/PD-L1 inhibitors with anti-angiogenic agents in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Hengzhou Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.